- Home
- DRK vs LSTA Comparison
DRK vs LSTA Comparison
Compare DRK & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.58
Company Overview
Basic Information| Metric | DRK | LSTA |
|---|---|---|
| Founded | N/A | 1980 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Misc Health and Biotechnology Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.9M | 28.9M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | DRK | LSTA |
|---|---|---|
| Price | $3.03 | $1.58 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $15.00 |
| AVG Volume (30 Days) | N/A | ★ 366.4K |
| Earning Date | N/A | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 20.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $35,283,868.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 56.90 |
| 52 Week Low | N/A | $0.99 |
| 52 Week High | N/A | $5.07 |
Technical Indicators
Market Signals| Indicator | DRK | LSTA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 47.50 |
| Support Level | N/A | $1.11 |
| Resistance Level | N/A | $2.08 |
| Average True Range (ATR) | 0.00 | 0.27 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 25.34 |
Price Performance
Historical Comparison DRK
LSTA
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.